Skip to content
Research Article Open access CC BY 4.0

Interleukin 3 as an Erythropoietic Marker in Human Immunodeficiency Virus and Hepatitis B Positive Patients in South East Nigeria

Chinenye E. Okenwa, Ijeoma C. Uzoma, Anulika O. Onyemelukwe, Ogechukwu C. Dozie- Nwakile, Hilary Emuebie, Victor C. Edeh, S. A. Ufelle

Annual Research & Review in Biology · pp. 1–8 · Published 27 Jun 2020

10.9734/arrb/2020/v35i630231

Abstract

Aim: To evaluate the interleukin 3 levels in some Hepatitis B virus and Human immunodeficiency virus (HIV) positive subjects. Study Design: Cross sectional study. Place and Duration of Study: Haematology Department, University of Nigeria Teaching Hospital Enugu, Nigeria, between June and September, 2019. Methodology: A total of 86 subjects were recruited for this study; 40 were positive for the human immunodeficiency virus, 30 were Hepatitis B positive and 16 healthy subjects that served as controls. The controls had tested negative to Hepatitis B Virus, Human immunodeficiency Virus and hepatitis C virus infections. Whole blood samples were collected from the Human immunodeficiency Virus positive and control samples. Haemoglobin concentration was analysed using the Orphěe Mythic 22 automated analyzer. Serum samples collected from all 86 subjects were used to assay Interleukin 3 using the Enzyme Linked Immunosorbent assay based Finetest human interleukin 3 kit. Results: A highly significant decrease in interleukin 3 levels was observed in Hepatitis B Virus and Human immunodeficiency virus positive subjects when compared with the apparently healthy control subjects, (P = 0.000 < 0.05). Average hemoglobin levels were also lower in the Human immunodeficiency virus subjects compared with the controls. Conclusion: A reduction of the interleukin 3 may be part of the synergistic factors responsible for the anaemia usually seen in the viral infections.

Interleukin 3 haemoglobin hepatitis B human immunodeficiency virus erythropoiesis cytokines growth factors

References (45)

  1. 1 Hepatitis B Virus Immunopathogenesis [DOI]
  2. 2 Interleukin-10 Therapy—Review of a New Approach [DOI]
  3. 3 Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes [DOI]
  4. 4 Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites [DOI]
  5. 5 Hematopoietic cytokines [DOI]
  6. 6 Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection†‡ [DOI]
  7. 7 Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis [DOI]
  8. 8 Viral hepatitis and HIV coinfection [DOI]
  9. 9 Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems [DOI]
  10. 10 Cytokine receptors and hematopoietic differentiation [DOI]
  11. 11 Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID) [DOI]
  12. 12 Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output [DOI]
  13. 13 Hepatitis B virus and human immunodeficiency virus co‐infection in sub‐Saharan Africa: a call for further investigation [DOI]
  14. 14 Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections [DOI]
  15. 15 Interleukin‐35 in immune‐related diseases: protection or destruction [DOI]
  16. 16 Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection [DOI]
  17. 17 Clinical reviews in allergy and immunology
  18. 18 Cytokines and T-Cell Homeostasis in HIV Infection [DOI]
  19. 19 Serum Immunoreactive Erythropoietin in HIV-Infected Patients [DOI]
  20. 20 Recombinant erythropoietin in clinical practice [DOI]
  21. 21 Interleukin 6 inhibits HBV entry through NTCP down regulation [DOI]
  22. 22 Haematological changes in HIV infection with correlation to CD4 cell count [DOI]
  23. 23 Haematological manifestations of human immune deficiency virus infection [DOI]
  24. 24 Haemopoietic processes in allergic disease: eosinophil/basophil development [DOI]
  25. 25 Association of cytokines in hepatitis E with pregnancy outcome [DOI]
  26. 26 IL-4 Suppresses the Expression and the Replication of Hepatitis B Virus in the Hepatocellular Carcinoma Cell Line Hep3B [DOI]
  27. 27 Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection [DOI]
  28. 28 Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. [DOI]
  29. 29 Effects of recombinant human interleukin-3 in aplastic anemia [DOI]
  30. 30 Human Immunodeficiency Virus Infection, Anemia, and Survival [DOI]
  31. 31 Immune Dysfunction in HIV: A Possible Role for Pro- and Anti-Inflammatory Cytokines in HIV Staging [DOI]
  32. 32 Interleukin-1 and hematopoiesis [DOI]
  33. 33 Treatment for anemia in people with AIDS [DOI]
  34. 34 Clinico-haematological profile of patients with bicytopenia [DOI]
  35. 35 Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection [DOI]
  36. 36 Interleukin‐11 (IL‐11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells [DOI]
  37. 37 Hepatitis B virus infection [DOI]
  38. 38 Immunological Mechanisms of Interleukin-2 (IL-2) Treatment in HIV/AIDS Disease [DOI]
  39. 39 Administration of Porcine Interleukin-3 Induces Increased Levels of Blood Eosinophils [DOI]
  40. 40 Interleukin-3 in gene therapy of cancer.
  41. 41 Cytokines in Haemopoietic Progenitor Mobilisation for Peripheral Blood Stem Cell Transplantation [DOI]
  42. 42 Pilot study of recombinant human interleukin 2 for chronic type B hepatitis [DOI]
  43. 43 Bone Marrow Findings after Treatment with Recombinant Human Interleukin-3 [DOI]
  44. 44 Prospects for IL-16 in the treatment of AIDS [DOI]
  45. 45 Managing Anemia in HIV-Positive Women [DOI]

Cited by 1

Article metrics

Real usage data collected on this platform.

89

Page views

0

PDF downloads

44

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.